CMChristopher W. McIntyre

Christopher W. McIntyre

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher W. McIntyre has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Acute Cardiac Effects of Dialysis

    by Nicholas M. Selby, Christopher W. McIntyre

    It is well recognized that the procedure of hemodialysis is associated with significant changes in blood pressure and systemic hemodynamics; 20–30% of treatments are complicated by intradialytic hypotension (IDH). There are now an increasing number of studies using electrocardiographic, isotopic and echocardiographic techniques that show that subclinical myocardial ischemia occurs during dialysis. This concept is supported by some studies showing that dialysis can induce acute rises in troponins and creatinine kinase MB, although this has not been found by all authors. Some of this controversy may at least in part be due to the collection of blood samples immediately postdialysis, which is likely to be too early to reliably detect dialysis‐induced elevations of cardiac enzymes. Cardiovascular death is the biggest single cause of mortality in dialysis patients and of this sudden death comprises the largest proportion. As such, there is a large body of evidence examining whether dialysis is pro‐arrhythmogenic. It is clear that dialysis can increase QTc interval and QT dispersion and is capable of inducing arrhythmias on Holter monitoring, likely due to the interaction of multiple factors, some of which prime for the development of arrhythmias (particularly the presence of preexisting cardiac disease), and some of which act as triggers. However, the link between these electrocardiographic alterations and sudden death is relatively poorly studied. This review summarizes the available literature regarding the acute cardiac effects of dialysis in relation to the above, and discusses how these acute changes may contribute to the genesis of uremic cardiomyopathy and longer term cardiac outcomes.


  • VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: The Functional Cardiovascular Consequences of Vascular Calcification

    by Christopher W. McIntyre

    Calcification of the cardiovascular system is now well recognized to be a common feature of patients with chronic kidney disease. It is increasingly prevalent in patients with more severe uremia, particularly those receiving dialysis. Furthermore, it is progressive in terms of both severity and associated functional cardiovascular consequences. Although well recognized to be associated with a markedly increased mortality rate, the pathophysiological processes that result in these poor outcomes are less well understood. This article attempts to review calcification of the cardiovascular system as a whole entity and how the structural and functional changes may translate to the observed patterns of disease seen in these patients.


  • Open Access

    A systematic review of the clinical effects of reducing dialysate fluid temperature

    by Nicholas M. Selby, Christopher W. McIntyre

    Background. Intradialytic hypotension (IDH) is a frequent complication of haemodialysis. Reducing the temperature of the dialysis fluid is a simple therapeutic strategy but is relatively underused. This may be due to concerns regarding its effects on symptoms and dialysis adequacy. We performed a systematic review of the literature to examine the effects of cool dialysis on intradialytic blood pressure, and to assess its safety in terms of thermal symptoms and small solute clearance. Methods. We searched the Cochrane Central Register of Controlled Trials, Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, databases of ongoing trials, the contents of four major renal journals as well as hand-searching reference lists. We included all prospective randomized studies that compared any technique of reducing dialysate temperature with standard bicarbonate dialysis. These techniques included an empirical, fixed reduction of dialysate temperature or use of a biofeedback temperature-control device (BTM®) to deliver isothermic dialysis or programmed patient cooling. Results. A total of 22 studies comprising 408 patients were included (16 studies examined a fixed empirical temperature reduction and six examined BTM). All studies were of crossover design and relatively short duration. IDH occurred 7.1 (95% CI, 5.3–8.9) times less frequently with cool dialysis (both fixed reduction and BTM). Post-dialysis mean arterial pressure was higher with cool-temperature dialysis by 11.3 mmHg (95% CI, 7.7–15.0). No studies reported that cool dialysis led to a reduction in dialysis adequacy as assessed by urea clearance. The frequency and severity of thermal-related symptoms were generally reported inadequately. Conclusions. Reducing the temperature of the dialysate is an effective intervention to reduce the frequency of IDH and does not adversely affect dialysis adequacy. This applies to the fixed reduction of dialysate temperature and BTM. It remains unclear as to what extent cool-temperature dialysis causes intolerable cold symptoms during dialysis. There are no trials comparing fixed empirical temperature reduction with BTM, and no trials examining the long-term effects of cool dialysis on patient outcomes.


  • Open Access

    Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease

    by Christopher W. McIntyre, Nicholas M. Selby, Mhairi Sigrist, Lyndsay E. Pearce, Thomas H. Mercer, Patrick F. Naish

    Background. Chronic renal replacement therapy patients exhibit reduction in skeletal muscle function as a result of a combination of metabolic effects and muscle fibre size reduction. The aim of this study was to compare muscle mass with function in patients with chronic kidney disease (CKD) at stages 4 and 5 on haemodialysis (HD) and peritoneal dialysis (PD), and investigate the associations of muscle wasting in a cross-sectional cohort. Methods. We studied 134 patients (60 HD, 28 PD and 46 CKD 4). The three groups were well matched for age, sex, diabetes and dialysis vintage. Cross-sectional area (CSA) of muscle and fat was measured from a standardized multi-slice CT scan of a 6 cm long section of thigh. CSA of soft tissue was taken from appropriate fat and muscle densities. Functional assessment was by the sit-to-stand 60 test, assessing both the number of sit-to-stands possible under controlled conditions in 60 s (STS 60), and the time taken to perform five sit-to-stand movements (STS 5). Data were collected on a wide range of potential determinants of muscle CSA. Results. There were no significant differences in haemoglobin between males or females or between any of the groups studied. Serum phosphate and calcium-phosphate product were higher in HD patients as compared to CKD4 patients, but there were no differences in these variables when comparing PD patients with either CKD4 or HD patients. Muscle CSA correlated well with objective functional assessments in males (STS 60 R = 0.52, PR = 0.41, P = 0.004), and STS performance was reduced in dialysed patients as compared with CKD 4. Univariate analysis demonstrated that muscle CSA was associated with serum albumin concentration (R = 0.49, PR = −0.35, P = 0.005) and C-reactive protein (R = −0.34, P = 0.004). Creatinine clearance, dialysis adequacy, dialysis vintage and time-averaged serum bicarbonate, calcium and phosphate concentrations were not correlated with muscle CSA. Conclusion. In conclusion, patients with dialysis-treated CKD 5 exhibited more functionally significant muscle wasting than patients with CKD 4. This may be amenable to modification with targeted exercise or amelioration of factors associated with observed differences in muscle mass.


  • Open Access

    Reply

    by Christopher W. McIntyre, Nicholas J. Selby

    1Department of Renal Medicine Derby City Hospital2 Centre for Integrated Systems Biology and Medicine University of Nottingham UK

  • Open Access

    An unusual case of renovascular hypertension–renal artery stenosis of a pelvic kidney with aberrant blood supply

    by William S. Priestman, Mario DeNunzio, Maarten W. Taal, Richard J. Fluck, Christopher W. McIntyre

    Mr. G.L. aged 32 was referred to the Department of Renal Medicine at Derby City Hospital with unexplained hypertension. At 13 years of age he had suffered a cerebrovascular accident causing a left hemiparesis. At the time there were no risk factors identified to account for his stroke including normal intracerebral arteries. During his late teens he developed hypertension, which was controlled with Atenolol and Bendrofluazide. Three years prior to his referral to the Renal Department, he underwent investigation for hypertension revealing no evidence of secondary causes. An ultrasound scan at that time, showed two normal-sized kidneys but with the left kidney in a pelvic position.


  • Open Access

    Length of interdialytic interval influences serum calcium and phosphorus concentrations

    by Mhairi K. Sigrist, Lisa Devlin, Maarten W. Taal, Richard J. Fluck, Christopher W. McIntyre

    Background. Higher levels of serum phosphorus and calcium are associated with increased haemodialysis (HD) patient mortality. Both of these factors act synergistically to promote vascular smooth muscle differentiation to an osteoblast-like phenotype and subsequent vascular calcification. The aim of this study was to investigate the influence of interdialytic interval on serum levels, as well as the influence of oral calcium-based phosphate binder load on the magnitude of the observed differences. Methods. We studied 100 patients undergoing HD three times per week, over a 2 week period. Haemoglobin, albumin, calcium and phosphate were measured pre-dialysis before each HD session. Oral phosphate binder usage was recorded. All patients were treated with dialysate containing 1.25 mEq/l calcium. Results. Both mean serum phosphate and calcium were higher after the long interdialytic interval (1.59±0.05 vs 1.45±0.04 mmol/l, P = 0.0005, and 2.46±0.03 vs 2.4±0.02 mmol/l, P = 0.001, for serum phosphate and uncorrected calcium, respectively). There were no significant differences in haemoglobin or serum albumin, indicating that variable dilution from an increased hydration status in the long interdialytic interval was unlikely to contribute to these observed differences. A total of 74 patients were treated with calcium-containing binders and 26 patients with sevelamer. Patients on sevelamer did not exhibit the observed cyclical increase in serum calcium seen in patients on calcium-containing binders (mean difference in serum calcium 0.09±0.01 mmol/l in the calcium-treated group vs 0.01±0.01 mmol/l in the sevelamer-treated patients, P = 0.0004). The increase in serum calcium after the long interval as compared with the short interval was proportional to the daily amount of the oral calcium-containing binder load ingested (r = 0.63, PConclusion. Cyclical differences in interdialytic interval and overall exposure to both dietary phosphate and oral calcium load influence serum levels. This may have consequences for registry reporting, therapy modulation and potentially the pathogenesis of accelerated vascular calcification seen in HD patients.


  • Open Access

    Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness

    by Lindsay J. Chesterton, Mhairi K. Sigrist, Terence Bennett, Maarten W. Taal, Christopher W. McIntyre

    Introduction. Vascular calcification is a critical determinant of cardiovascular morbidity and mortality in chronic haemodialysis (HD) patients. The pathophysiology underlying this observation remains obscure. Baroreceptor sensitivity (BRS) is important in the maintenance of an appropriate cardiovascular status both at rest and under the physiological stress of HD. BRS is determined by both the mechanical properties of the vascular wall, mediating the transfer of transmural pressure, and afferent and efferent autonomic function. We aimed to study the association between arterial structure, function and BRS in chronic HD patients. Methods. We studied 40 chronic HD patients mean age 62±2 (26–86) years who had received HD for a mean 40±4 (9–101) months. Spontaneous BRS was assessed using software studying the relationship between inter-beat variability and beat to beat changes in systolic blood pressure. Functional characteristics of conduit arteries (pulse wave analysis) were studied with applanation tonometry at the radial artery. Arterial calcification was assessed in lower limbs using reconstructed multi-slice computed tomography and quantified with volume-corrected calcification scores within the superficial femoral artery. Results. Mean BRS was 4.43±0.44 ms/mmHg, with a wide range from 1.0 to 11.5 ms/mmHg. This correlated with arterial stiffness as measured by time to shoulder calculated from the central pulse wave analysis (r = 0.4, P = 0.01). BRS was also associated with vascular calcification (P = 0.01) but not by other factors such as dialysis vintage, age or pre-dialysis systolic/diastolic blood pressure. Conclusion. The reduction in BRS and the resulting aberrant blood pressure response to the physiological stress and volume changes of HD may be important in the further understanding of the pathophysiology of the increased mortality in HD patients with vascular calcification.


  • Prospective study of gentamicin locking of tunnelled dialysis catheters: The effect on infection rates and CRP

    by Stewart H. Lambie, Lisa J. Hulme, Maarten Taal, Richard J. Fluck, Christopher W. Mcintyre